首页 › 基金 › Rosalind Advisors, Inc. › OVID
Rosalind Advisors, Inc. 对 OVID 的持仓历史
OVID THERAPEUTICS INC · 医疗保健
Rosalind Advisors, Inc. 在 Q3 2026 的 13F 申报中披露持有 OVID(OVID THERAPEUTICS INC)1,107,994 股,市值约 US$2.8M,约占其申报组合的 1.13%,在其申报持仓中市值排名第 18 位。 Rosalind Advisors, Inc. 最近 6 个申报季度中有 4 个季度披露了 OVID 持仓,最早可追溯至 Q2 2025。
最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR
Rosalind Advisors, Inc. 对 OVID 的持仓演变
Rosalind Advisors, Inc. 于 Q2 2025 首次披露 OVID 持仓:500,000 股(约 US$165K)。 该持仓在 Q2 2026 达到峰值 1,107,994 股,市值约 US$3.0M。 在 4 次申报中,Rosalind Advisors, Inc. 的持股数量始终未变。 最近一期申报(Q3 2026)显示持股 1,107,994 股、市值约 US$2.8M。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2025 | 500.00K | $164.95K | 新进 |
| Q1 2026 | 1.11M | $2.46M | 新进 |
| Q2 2026 | 1.11M | $2.98M | 持有 |
| Q3 2026 | 1.11M | $2.76M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 OVID 与 13F 数据
OVID(OVID THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 51 只申报持有 OVID,申报仓位最大的包括:Affinity Asset Advisors, LLC (US$25.3M), SILVERARC CAPITAL MANAGEMENT, LLC (US$14.8M), ADAR1 Capital Management, LLC (US$11.4M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 OVID 的基金
- Affinity Asset Advisors, LLC 10.14M 股 · $25.26M · Q3 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 5.95M 股 · $14.82M · Q3 2026
- ADAR1 Capital Management, LLC 4.56M 股 · $11.36M · Q3 2026
- Ikarian Capital, LLC 2.27M 股 · $6.11M · Q2 2026
- Propel Bio Management, LLC 1.02M 股 · $2.54M · Q3 2026
- Sio Capital Management, LLC 1.01M 股 · $2.50M · Q3 2026
- Ally Bridge Group (NY) LLC 624.56K 股 · $1.68M · Q2 2026
更多关于 Rosalind Advisors, Inc.
常见问题
How long has Rosalind Advisors, Inc. held OVID?
Rosalind Advisors, Inc. has disclosed OVID holdings in 4 of the last 6 reported quarters, going back to Q2 2025.
What is Rosalind Advisors, Inc.'s current position in OVID?
As of Q3 2026, Rosalind Advisors, Inc. holds 1.11M shares of OVID (OVID THERAPEUTICS INC), valued at $2.76M, representing 1.13% of its reported portfolio and ranking #18.
Has Rosalind Advisors, Inc. been buying or selling OVID?
In the latest 13F filing (Q3 2026), Rosalind Advisors, Inc. held unchanged its position in OVID. The position peaked in Q2 2026 at 1.11M shares.
Which other funds hold OVID?
Other major institutional holders of OVID include Affinity Asset Advisors, LLC, SILVERARC CAPITAL MANAGEMENT, LLC, ADAR1 Capital Management, LLC, among 51 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.